Pharmacist's Verdict
Claritin is a reliable, non-drowsy choice for managing mild to moderate daily allergy symptoms, but it may not be strong enough for those with severe allergies.
Ingredient Analysis
Loratadine 10 mg
Pros & Cons
Pros
- Non-drowsy formula for most users, making it suitable for daytime use.
- Convenient once-daily dosing.
- Well-tolerated with a long history of safe use and few side effects.
- Widely available in affordable generic versions.
- Fewer drug interactions compared to many other medications.
Cons
- May be less potent than newer antihistamines like cetirizine (Zyrtec) or fexofenadine (Allegra).
- Can take 1-3 hours to start working, so it's not for immediate symptom relief.
- A small number of people may still experience some drowsiness.
- Effectiveness can feel reduced for some long-term users.
Safety Information
Warnings
Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness. Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Is Claritin safe for you?
See pregnancy, interactions, and common concerns answered in our pharmacist safety FAQ.
Read safety review →References
- 1.FDA Drug Label — allergy relief
FDA DailyMed: allergy relief · FDA
- 2.FDA Drug Label — Claritin Chewable Grape and Bubblegum
FDA DailyMed: Claritin Chewable Grape and Bubblegum · FDA
- 3.Allergic Rhinitis: A Review.
Bernstein JA, Bernstein JS, Makol R, et al., JAMA, 2024 · PubMed
- 4.Efficacy of different oral H(1) antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials.
Hong D, Weng J, Ye M, et al., Brazilian journal of otorhinolaryngology, 2023 · PubMed
- 5.Acupuncture for allergic rhinitis: a systematic review and meta-analysis.
He M, Qin W, Qin Z, et al., European journal of medical research, 2022 · PubMed
- 6.Second-generation antihistamines: a comparative review.
Slater JW, Zechnich AD, Haxby DG, Drugs, 1999 · PubMed